MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Tonsillectomy and risk of Parkinson’s disease: A Danish nationwide population-based cohort study

    E. Svensson, V. Henderson, S. Szépligeti, M. Stokholm, T. Klug, H. Sørensen, P. Borghammer (Aarhus, Denmark)

    Objective: To our knowledge, no studies have examined whether the lymphoid tissue of the tonsils are involved PD, or whether tonsillectomy modifies the risk of PD.…
  • 2017 International Congress

    Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

    K. Fifel (Leiden, Netherlands)

    Objective: The aim of this study is to investigate the circadian and homeostatic modulation of the multi-unit activity of dopamineric and striatal neuronal structures. Background:…
  • 2017 International Congress

    Two-year prospective study reveals that gut dysbiosis predicts progression of Parkinson’s disease

    M. Hirayama, T. Minato, Y. Fujisawa, H. Tsuji, T. Asahara, K. Nomoto, T. Maeda, K. Ohno (Nagoya, Japan)

    Objective:  This study is to examine whether intestinal microbiota correlate with pathology progress of PD severity and change of gut microbiota for 2 years. Background:…
  • 2017 International Congress

    Relationship between sleep profiles and clinical features in Parkinson’s disease

    Y.-Y. Lin, R.-S. Chen, C.-S. Lu, Y.-Z. Huang, Y.-H. Weng, T.-H. Yeh, W.-Y. Lin, J. Hung (Taoyuan, Taiwan)

    Objective: To document the prevalence of sleep disturbance and excessive daytime sleepiness (EDS) in Taiwanese Parkinson’s disease (PD) patients and to identify the risk factors…
  • 2017 International Congress

    Does gender influence the expression of non-motor symptoms in Parkinson’s disease?: An observational study

    J. Herreros Rodríguez, A. Esquivel López, R. Gordo Mañas, Á. Sánchez Ferro (Madrid, Spain)

    Objective: Our goal was to evaluate how gender influenced the expression of non-motor symptoms in a sample of PD patients. Background: Parkinson’s Disease (PD) is defined…
  • 2017 International Congress

    Histological analysis of α-synuclein pathology in the circadian system in Parkinson’s disease

    E. De Pablo-Fernandez, J. Holton, T. Warner (London, United Kingdom)

    Objective: Assessment of severity of α-synuclein pathology in the circadian system in patients with Parkinson’s disease (PD). Background: Circadian system is responsible for the 24-hour…
  • 2017 International Congress

    Effect of Urinary Dysfunction on Depression and Anxiety Development in Parkinson’s Disease

    E. Benli, F. Ozer, N. Helvaci Yilmaz, T. Ozcan, O. Arici Duz (Ordu, Turkey)

    Objective: To investigate the relationship between urinary dysfunction (UD) and anxiety and depression in Parkinson's Disease (PD).    Background: Urinary dysfunction is one of the…
  • 2017 International Congress

    Motor performance measured with the UPDRS in PD patientswith varying degrees of smell loss

    c. cox, A. Kahttab, K. Amar (Bournemouth. Dorset, United Kingdom)

    Objective: To establish whether there is a possible link between the motor symptoms, which includes RBD in PD patients in this study, who have mild/moderate…
  • 2017 International Congress

    Clean intermittent catheterization in Parkinson’s disease: a case report

    M. Tosin, C. Mecone, W. Macedo, A.P. Seabra, A. Barbosa, R. Sakakibara (RIO DE JANEIRO, Brazil)

    Objective: Describe the interdisciplinary actions that resulted in the therapeutic indication of a clean intermittent bladder catheterization in a patient with detrusor areflexia related to…
  • 2017 International Congress

    Cerebrospinal Fluid Levels of Coenzyme Q10 are Reduced in Multiple System Atrophy

    Y. Compta, F. Antonelli, M. Fernandez, P. Bravo, M. Soto, A. Camara, D.M. Giraldo, M.J. Marti, On-behalf-of Catalan-MSA-Registry Group (Barcelona, Spain)

    Objective: To assess CSF levels of coenzyme Q10 in multiple system atrophy (MSA) vs. Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and control subjects without…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley